The Evidence Speaks (June 2022)
This edition includes preparing patients for colorectal surgery, exome sequencing's impact on health care utilization, and cardiovascular events in people with glomerular diseases
Read MoreMay 17, 2022
This edition includes preparing patients for colorectal surgery, exome sequencing's impact on health care utilization, and cardiovascular events in people with glomerular diseases
Read More
CHÉOS Scientist Dr. Annalijn Conklin aims to understand how gender and changes in social ties can impact blood pressure and body weight in an aging population
Read More
CHÉOS Scientists are leading nine of the projects funded in this round, plus a further seven projects are supported by CHÉOS Scientists as co-investigators
Read More
Dr. Annalijn Conklin was awarded a 2021 Michael Smith Foundation for Health Research (MSFHR) Scholar Award. Their Scholar project is titled, “A program of social epidemiology and metabolic outcomes research (SEMOR) to support healthy aging.”
Read More
Scientist Dr. Annalijn Conklin and trainees Drs. Kirsten Marchand and Krista Glowacki were successful in this round of competitions
Read More
CHÉOS Scientists are leading eight of the projects funded in this round, plus a further fourteen projects are supported by CHÉOS Scientists as co-investigators
Read More
CHÉOS Scientists are testing the cost-effectiveness of adding a new blood test to improve prostate cancer screening
Read More
The newest member of our team is an expert in outcomes research, administrative data, and epidemiology…and lived experience
Read More
As we adjust our clocks for Daylight Saving Time, Dr. Annalijn Conklin and Kexin Zhang discuss some of the longer-term impacts of sleep disturbance on health
Read More
This edition includes major depressive disorder treatment coverage, social connections and hypertension, and paramedic experiences of the overdose response
Read More